Meningococcal Disease: Shifting Epidemiology and Genetic Mechanisms That May Contribute to Serogroup C Virulence

Genotypic and Phenotypic Modifications of Neisseria meningitidis after an Accidental Human Passage

(2011) Hélène Omer et al.   PLoS One

The epidemiology of meningococcal disease and the impact of vaccines

(2010) Ameneh Khatami et al.   Expert Review of Vaccines

Emergence of New VirulentNeisseria meningitidisSerogroup C Sequence Type 11 Isolates in France

(2010) Ala‐Eddine Deghmane et al.   JOURNAL OF INFECTIOUS DISEASES

Population Structure and Capsular Switching of InvasiveNeisseria meningitidisIsolates in the Pre–Meningococcal Conjugate Vaccine Era—United States, 2000–2005

(2010) Lee H. Harrison et al.   JOURNAL OF INFECTIOUS DISEASES

The Influence of IS1301 in the Capsule Biosynthesis Locus on Meningococcal Carriage and Disease

(2010) Elisabeth Kugelberg et al.   PLoS One

Genome Sequencing Reveals Widespread Virulence Gene Exchange among Human Neisseria Species

(2010) Pradeep Reddy Marri et al.   PLoS One

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

(2010) J. Donnelly et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Human antibody responses to the meningococcal factor H binding protein (LP2086) during invasive disease, colonization and carriage

(2010) Dlawer A.A. Ala’Aldeen et al.   VACCINE

Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease

(2010) Han-Qing Jiang et al.   VACCINE

Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal Disease

(2009) Amanda C. Cohn et al.   CLINICAL INFECTIOUS DISEASES

Evidence for Capsule Switching between Carried and Disease-Causing Neisseria meningitidis Strains

(2009) A. J. Beddek et al.   INFECTION AND IMMUNITY

Meningococcal Factor H–Binding Protein Variants Expressed by Epidemic Capsular Group A, W‐135, and X Strains from Africa

(2009) P. T. Beernink et al.   JOURNAL OF INFECTIOUS DISEASES

Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development

(2009) Helena Lo et al.   LANCET INFECTIOUS DISEASES

Emergence of Ciprofloxacin-ResistantNeisseria meningitidisin North America

(2009) Henry M. Wu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Meningococcal C conjugate vaccine: The experience in England and Wales

(2009) Helen Campbell et al.   VACCINE

Molecular surveillance of Neisseria meningitidis capsular switching in Portugal, 2002–2006

(2008) M. J. SIMÕES et al.   EPIDEMIOLOGY AND INFECTION

A generic mechanism inNeisseria meningitidisfor enhanced resistance against bactericidal antibodies

(2008) Maria Jose Uria et al.   JOURNAL OF EXPERIMENTAL MEDICINE